Search Results - "Brudieux, E."
-
1
Hepatic porphyrin concentration and uroporphyrinogen decarboxylase activity in hepatitis C virus infection
Published in Journal of viral hepatitis (01-01-2001)“…Previous studies have shown a high prevalence of hepatitis C virus (HCV) infection in patients with porphyria cutanea tarda (PCT). The aim of this study was to…”
Get full text
Journal Article -
2
Patterns of Use, Safety, and Effectiveness of Targeted Therapies in First-Line Treatment of Metastatic Colorectal Cancer According to Age: The STROMBOLI Cohort Study
Published in Clinical colorectal cancer (01-03-2019)“…Metastatic colorectal cancer (mCRC) is increasingly treated using targeted therapies. Their real-life evaluation is insufficient, especially in elderly and…”
Get full text
Journal Article -
3
Quality indicators for colorectal cancer surgery and care according to patient-, tumor-, and hospital-related factors
Published in BMC cancer (19-07-2012)“…Colorectal cancer (CRC) care has improved considerably, particularly since the implementation of a quality of care program centered on national evidence-based…”
Get full text
Journal Article -
4
Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: The influence of virus C infection
Published in Hepatology (Baltimore, Md.) (01-02-1998)“…Porphyria cutanea tarda (PCT) is caused by a decreased activity of the hepatic enzyme uroporphyrinogen decarboxylase (URO‐D). This deficiency causes…”
Get full text
Journal Article -
5
-
6
Hepatic porphyrin concentration and uroporphyrinogen decarboxylase activity in hepatitis C virus infection
Published in Journal of viral hepatitis (01-01-2001)“…Previous studies have shown a high prevalence of hepatitis C virus (HCV) infection in patients with porphyria cutanea tarda (PCT). The aim of this study was to…”
Get full text
Journal Article -
7